NYSE · USPH

US Physical Therapy Inc.

$74.58 +$1.61 (+2.21%) 1D Market open

Key Metrics

$1.11B
Market cap
31.98×
P/E · TTM
$795.49M
Revenue · TTM
$34.72M
Net income
EPS · TTM $2.29
Dividend yield
Free cash flow $66.68M
Beta · 1Y 0.73
EBITDA · TTM $93.57M
Gross margin 19.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 14
    The stock moved +8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14
  • May 7
    From its Feb 11 high, the share price fell 33%.

    Peak close $88.14 on Feb 11; trough close $59.00 on May 7. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%
  • May 7
    The stock moved -19.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.11B
Enterprise value$1.29B
Shares outstanding15.2M
52-wk range$58.19 – $93.50
Avg volume · 20D108.6K
Net cash −$176.40M
Book value / share$30.99
IndustryServices-Health Services
ExchangeNYSE
About US Physical Therapy Inc.
IPO dateMay 28, 1992
Employees7294

US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E31.98
P/S1.40
P/FCF16.66
EV/EBITDA13.75
EV/Sales1.62
Graham №$40.00

Profitability

Gross 19.0%
Operating 8.9%
Net 4.4%
FCF 8.4%
ROE / ROIC 7.2% · 8.2%

Financial Health

Current ratio1.19
Quick ratio
Debt / equity0.44
Debt / EBITDA 2.19
Net cash −$176.40M
Working capital$21.81M

Cash Flow · TTM

Operating CF $83.54M
Capex −$16.87M
Free cash flow $66.68M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

2.5
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$40.00 vs $74.58
Trades 1.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings